MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Parkin Coregulates Glutathione Metabolism in Adult Brain to Contribute to Redox Homeostasis

    D. El Kodsi, J. Tokarew, R. Sengupta, A. Chatterji, M. Takanashi, N. Hattori, J. Tomlinson (Ottawa, Canada)

    Objective: We sought to determine whether the expression of PRKN, a young-onset Parkinson disease-linked gene, confers redox homeostasis in vivo. Background: The mechanisms by which…
  • 2023 International Congress

    Functional network correlates of APOE ε4 allele in Parkinson’s disease

    K. Schindlbeck, A. Vo, P. Mattis, N. Nguyen, D. Eidelberg (Munich, Germany)

    Objective: To investigate the influence of APOE ε4 allele on metabolic network activity and functional connectivity in patients with Parkinson's disease (PD). Background: Disease progression…
  • 2023 International Congress

    Automated parcellation of the cerebellum in patients with newly diagnosed Parkinson’s disease

    B. Facer, C. de Bezenac, A. Macerollo, T. Butts, R. Sadavarte, J. Farah, S. Keller (Liverpool, United Kingdom)

    Objective: Quantitatively evaluate the gross morphology of individual cerebellar lobules, determine whether cerebellar anatomical changes occur early in the disease and whether changes were related…
  • 2023 International Congress

    Electronic Development of the MDS-UPDRS and MDS-NMS: Process and User Feedback

    R. Fuller, M. Monje, A. Sanchez Ferro, T. Mestre, L. Chahine, K. Dujardin, C. Fitzer-Attas, S. Groppa, S. Perez-Lloret, T. Turner, J. Youn, P. Martinez-Martin, G. Stebbins (Princeton, USA)

    Objective: To describe the processes for development and obtaining user feedback of the electronic versions of the MDS Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) and…
  • 2023 International Congress

    Speech difficulties and dopaminergic neurodegeneration in Parkinson’s Disease

    S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)

    Objective: To evaluate the association between speech difficulties and neurodegeneration of the putaminal dopaminergic system in people with early-stage treated with symptomatic therapy and advanced-stage…
  • 2023 International Congress

    Drivers of Health-Related Quality of Life in Parkinson’s Disease: non-motor symptoms and time spent in daily activities

    C. Painous, I. Pijuan, E. Tolosa (Barcelona, Catalonia)

    Objective: The purpose of this study was to identify factors associated with health-related quality of life (HRQoL) in people with Parkinson’s Disease (PwP). Background: HRQoL…
  • 2023 International Congress

    RT-QuIC for detection of pathological α-synuclein in the olfactory mucosa and CSF of Parkinson’s disease patients

    V. Tommasini, M. Bongianni, M. Catalan, D. Perra, P. Polverino, C. Bertolotti, R. Baruca, G. Bellavita, L. Antonutti, G. Zanusso, P. Manganotti (Trieste, Italy)

    Objective: To investigate the proficiency of RT-QuIC in detecting the presence of misfolded α-synuclein (α-syn) on the olfactory mucosa (OM) and CSF of patients with…
  • 2023 International Congress

    Financial impact of Parkinson’s disease on women and men

    C. Jiang, A. Liu, A. Ratnavel, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)

    Objective: To investigate whether financial impact of Parkinson’s disease (PD) differs for women and men. Background: PD poses a significant burden on affected individual financially.…
  • 2023 International Congress

    The contribution of Brain Bank for Aging Research to pathomechanism of Parkinson’s disease

    S. Murayama, Y. Saito (Osaka, Japan)

    Objective: Objective: The aim of this paper is to present the result of the whole body screening of Lewy body pathology by Brain Bank for…
  • 2023 International Congress

    Impaired Mitophagy and Mitochondrial-energetics in Parkinson’s disease: A Novel Therapeutic Strategy of Re-tasking Felodipine

    A. Roy, S. Choudhury, R. Banerjee, A. Costa, P. Sheshadri, M. Duchen, S. Dey, H. Kumar (Kolkata, India)

    Objective: This study aimed to validate impairment of mitochondrial energetics and mitophagy in PD and the action of felodipine in restoring altered Mitochondria-lysosome (Mito-Lyso) homeostasis.…
  • « Previous Page
  • 1
  • …
  • 373
  • 374
  • 375
  • 376
  • 377
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley